Vanessa Marchant

13PUBLICATIONS
34CO-AUTHORS
Experimental methods in fluid flow, heat and mass transferMolecular targetsMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 13, 2025
Troxerutin is a novel osmotic agent for peritoneal dialysis with protective cardiovascular actions.

Valeria Kopytina, Vanessa Marchant, Raquel Rodrigues-Diez

|Aug 14, 2025
STING inhibition alleviates experimental peritoneal damage: potential therapeutic relevance for peritoneal dialysis.

Vanessa Marchant, Jorge García-Giménez, Guadalupe T González-Mateo

|Jun 27, 2025
Dasatinib and Quercetin Combination Increased Kidney Damage in Acute Folic Acid-Induced Experimental Nephropathy.

Antonio Battaglia-Vieni, Vanessa Marchant, Lucia Tejedor-Santamaria

|Jun 26, 2025
The Role of miR-802 in Diabetic Kidney Disease: Diagnostic and Therapeutic Insights.

Antonio Tejera-Muñoz, Vanessa Marchant, Lucía Tejedor-Santamaría

|May 14, 2025
CCN2 Activates Cellular Senescence Leading to Kidney Fibrosis in Folic Acid-Induced Experimental Nephropathy.

Lucia Tejedor-Santamaria, Laura Marquez-Exposito, Alicia Villacampa

|Sep 14, 2024
Ccn2 Deletion Reduces Cardiac Dysfunction, Oxidative Markers, and Fibrosis Induced by Doxorubicin Administration in Mice.

Antonio Tejera-Muñoz, Marcelino Cortés, Alianet Rodriguez-Rodriguez

Pageof 3